Shih-Lung Cheng

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Coronavirus Disease

Allergic Rhinitis

Extracorporeal Membrane Oxygenation

Top Venues

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Felisbela Gomes, Shih-Lung Cheng
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System. Biomolecules 13 (3) (2023)
Felisbela Gomes, Shih-Lung Cheng
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System. Biomolecules 13 (3) (2023)
Felisbela Gomes, Shih-Lung Cheng
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System. Biomolecules 13 (3) (2023)
Cheng-Wei Liu, Shih-Lung Cheng
Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life (Basel, Switzerland) 12 (9) (2022)
Cheng-Wei Liu, Shih-Lung Cheng
Reply to Crimi, C.; Cortegiani, A. Comment on "Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12 , 1419". Life (Basel, Switzerland) 12 (10) (2022)
Chung-Jen Wang, Shih-Lung Cheng, Sow-Hsong Kuo
Asthma and COVID-19 Associations: Focus on IgE-Related Immune Pathology. Life (Basel, Switzerland) 12 (2) (2022)
Shih-Lung Cheng, Chau-Chyun Sheu, Chih-Feng Chian, Jeng-Yuan Hsu, Kuo-Chin Kao, Liang-Wen Hang, Ching-Hsiung Lin, Wen-Feng Fang, Hao-Chien Wang, Diahn-Warng Perng
NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan. Biomedicines 10 (10) (2022)
Shih-Lung Cheng
Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab. Life (Basel, Switzerland) 11 (8) (2021)
Hsu-Hui Wang, Shih-Lung Cheng
From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease. Biomedicines 9 (11) (2021)